Evidence map›Paper›PMID 29380243›Full record

ArticleMolecular and cellular biochemistry2018

Quercetin exerts an inhibitory effect on cellular bioenergetics of the B164A5 murine melanoma cell line.

Adrian Sturza, Ioana Pavel, Sebastian Ancușa, Corina Danciu, Cristina Dehelean, Oana Duicu, Danina Muntean

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Quercetin: A Potential Polydynamic Drug.Molecules (Basel, Switzerland) · 2023
    Review
  9. Phytochemicals Target Multiple Metabolic Pathways in Cancer.Antioxidants (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Phytochemical Constituents and Derivatives ofInternational journal of molecular sciences · 2023
    Review
  12. Review
  13. Pharmacological Activity of Quercetin: An Updated Review.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Targeting the pH Paradigm at the Bedside: A Practical Approach.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adrian SturzaDepartment of Pathophysiology - Functional Sciences, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timişoara, 2, Eftimie Murgu Sq., 300041, Timisoara, Romania.
Ioana PavelDepartment of Pharmacognosy, Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania.
Sebastian AncușaDepartment of Pathophysiology - Functional Sciences, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timişoara, 2, Eftimie Murgu Sq., 300041, Timisoara, Romania.
Corina DanciuDepartment of Pharmacognosy, Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania.
Cristina DeheleanDepartment of Toxicology, Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Timisoara, Romania.
Oana DuicuDepartment of Pathophysiology - Functional Sciences, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timişoara, 2, Eftimie Murgu Sq., 300041, Timisoara, Romania. oanaduicu@umft.ro.
Danina MunteanDepartment of Pathophysiology - Functional Sciences, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timişoara, 2, Eftimie Murgu Sq., 300041, Timisoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

The university grant PIII-C2-PCFI-2015/2016
6 · The paper itself

Abstract

Modulation of mitochondrial bioenergetics and glycolysis in malignancies has recently emerged a potential chemotherapeutic strategy since numerous malignant cells have overcome inhibition of the glycolytic pathway by increasing mitochondrial ATP production. Quercetin is a flavonoid with antioxidant, antiangiogenic, and chemoprotective properties but the mitochondrial effects are less characterized. The present study was purported to assess the effects of quercetin on the bioenergetic profile of B164A5 murine melanoma cell line. The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured at 24, 48, and 72 h of treatment of B164A5 murine melanoma cells with increasing concentrations (25, 50, 100, and 150 µM) of quercetin using the extracellular flux analyzer Seahorse XF24e (Seahorse Agilent). Analysis of mitochondrial function was performed in the presence of the classic modulators of the electron transport chain: oligomycin, FCCP, and rotenone. 72-h treatment with quercetin induced a dose-dependent decrease of all OCR parameters (basal respiration, proton leak, ATP turnover, maximal respiration, reserve capacity) as well as of ECAR. At variance, 48-h treatment induced a decrease of OCR and ECAR when quercetin was applied at 50, 100, and 150 µM, while the 24-h treatment induced a decrease of bioenergetic parameters only for the highest concentrations (100 and 150 µM) of the compound. Our data clearly demonstrated that quercetin elicited dose-dependent inhibitory effect on examined parameters of cellular bioenergetics that was most potent at 72 h of treatment. Thereby quercetin, modulating both glycolytic and mitochondrial pathways for ATP production, might be an efficient approach in killing cancer cells.

Indexed as

AnimalsCell Line, TumorEnergy MetabolismMelanomaMiceOxygen ConsumptionQuercetinQuercetinBioenergeticsFlavonoidsMetabolic functionMurine melanoma cell lineQuercetin

Identifiers

PMID29380243
OpenAlexW2791664208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.